Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 359

1.

Introducing and Prospective Efficacy Comparison of an Innovative and Affordable Technique for the Treatment of Distal Radius Fractures.

Yazdanshenas H, Washington ER 3rd, Madadi F, Madadi F, Shamie AN, Hornicek FJ, Azari K.

J Orthop. 2019 May 29;16(6):596-602. doi: 10.1016/j.jor.2019.05.007. eCollection 2019 Nov-Dec.

PMID:
31708608
2.

Correction to: Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation.

Feng Y, Liao Y, Zhang J, Shen J, Shao Z, Hornicek F, Duan Z.

Cell Commun Signal. 2019 Oct 29;17(1):138. doi: 10.1186/s12964-019-0462-z.

3.

Cancer Testis Antigens in Sarcoma: Expression, Function and Immunotherapeutic Application.

Wei R, Dean DC, Thanindratarn P, Hornicek FJ, Guo W, Duan Z.

Cancer Lett. 2019 Oct 18. pii: S0304-3835(19)30521-X. doi: 10.1016/j.canlet.2019.10.024. [Epub ahead of print]

PMID:
31634526
4.

Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation.

Feng Y, Liao Y, Zhang J, Shen J, Shao Z, Hornicek F, Duan Z.

Cell Commun Signal. 2019 Oct 14;17(1):125. doi: 10.1186/s12964-019-0440-5. Erratum in: Cell Commun Signal. 2019 Oct 29;17(1):138.

5.

Physical Function and Quality of Life After Resection of Mobile Spine Chondrosarcoma.

Paulino Pereira NR, Janssen SJ, Stoop N, Hartveldt S, Chen YE, DeLaney TF, Hornicek FJ, Schwab JH.

Global Spine J. 2019 Oct;9(7):743-753. doi: 10.1177/2192568219830330. Epub 2019 Feb 18.

6.

Exosomes promote pre-metastatic niche formation in ovarian cancer.

Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z.

Mol Cancer. 2019 Aug 13;18(1):124. doi: 10.1186/s12943-019-1049-4. Review.

7.

Long-term follow-up of custom cross-pin fixation of 56 tumour endoprosthesis stems: a single-institution experience.

Bernthal NM, Upfill-Brown A, Burke ZDC, Ishmael CR, Hsiue P, Hori K, Hornicek F, Eckardt JJ.

Bone Joint J. 2019 Jun;101-B(6):724-731. doi: 10.1302/0301-620X.101B6.BJJ-2018-0993.R1.

PMID:
31154850
8.

Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST.

Miao R, Wang H, Jacobson A, Lietz AP, Choy E, Raskin KA, Schwab JH, Deshpande V, Nielsen GP, DeLaney TF, Cote GM, Hornicek FJ, Chen YE.

Radiother Oncol. 2019 Aug;137:61-70. doi: 10.1016/j.radonc.2019.03.015. Epub 2019 May 9.

PMID:
31078939
9.

Advances in immune checkpoint inhibitors for bone sarcoma therapy.

Thanindratarn P, Dean DC, Nelson SD, Hornicek FJ, Duan Z.

J Bone Oncol. 2019 Jan 29;15:100221. doi: 10.1016/j.jbo.2019.100221. eCollection 2019 Apr. Review.

10.

Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Houdek MT, Rose PS, Hevesi M, Schwab JH, Griffin AM, Healey JH, Petersen IA, DeLaney TF, Chung PW, Yaszemski MJ, Wunder JS, Hornicek FJ, Boland PJ, Sim FH, Ferguson PC; Other Members of the Sacral Tumor Society.

J Surg Oncol. 2019 Jun;119(7):856-863. doi: 10.1002/jso.25399. Epub 2019 Feb 7.

PMID:
30734292
11.

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer.

Wang J, Dean DC, Hornicek FJ, Shi H, Duan Z.

FASEB J. 2019 May;33(5):5990-6000. doi: 10.1096/fj.201801789RR. Epub 2019 Feb 6.

PMID:
30726104
12.

Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.

Tang F, Min L, Seebacher NA, Li X, Zhou Y, Hornicek FJ, Wei Y, Tu C, Duan Z.

J Orthop Res. 2019 Mar;37(3):789-798. doi: 10.1002/jor.24227. Epub 2019 Feb 12.

PMID:
30667081
13.

Small-molecule targeting of brachyury transcription factor addiction in chordoma.

Sharifnia T, Wawer MJ, Chen T, Huang QY, Weir BA, Sizemore A, Lawlor MA, Goodale A, Cowley GS, Vazquez F, Ott CJ, Francis JM, Sassi S, Cogswell P, Sheppard HE, Zhang T, Gray NS, Clarke PA, Blagg J, Workman P, Sommer J, Hornicek F, Root DE, Hahn WC, Bradner JE, Wong KK, Clemons PA, Lin CY, Kotz JD, Schreiber SL.

Nat Med. 2019 Feb;25(2):292-300. doi: 10.1038/s41591-018-0312-3. Epub 2019 Jan 21.

14.

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma.

Ma H, Seebacher NA, Hornicek FJ, Duan Z.

EBioMedicine. 2019 Jan;39:182-193. doi: 10.1016/j.ebiom.2018.12.022. Epub 2018 Dec 20.

15.

Is malnutrition associated with postoperative complications in patients with primary bone sarcomas?

Park A, Lans J, Raskin K, Hornicek F, Schwab J, Lozano Calderon S.

J Surg Oncol. 2019 Mar;119(3):324-328. doi: 10.1002/jso.25332. Epub 2018 Dec 16.

PMID:
30554419
16.

Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey.

Dea N, Fisher CG, Reynolds JJ, Schwab JH, Rhines LD, Gokaslan ZL, Bettegowda C, Sahgal A, Lazáry Á, Luzzati A, Boriani S, Gasbarrini A, Laufer I, Charest-Morin R, Wei F, Teixeira W, Germscheid NM, Hornicek FJ, DeLaney TF, Shin JH; AOSpine Knowledge Forum Tumor.

J Neurosurg Spine. 2018 Oct 19;30(1):119-125. doi: 10.3171/2018.6.SPINE18362.

PMID:
30497218
17.

Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma.

Li X, Seebacher NA, Xiao T, Hornicek FJ, Duan Z.

J Orthop Res. 2019 Feb;37(2):510-521. doi: 10.1002/jor.24189. Epub 2019 Jan 3.

PMID:
30488489
18.

Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.

van Wulfften Palthe ODR, Tromp I, Ferreira A, Fiore A, Bramer JAM, van Dijk NC, DeLaney TF, Schwab JH, Hornicek FJ.

Spine J. 2019 May;19(5):869-879. doi: 10.1016/j.spinee.2018.11.002. Epub 2018 Nov 14.

PMID:
30445184
19.

RNA sequencing (RNA-Seq) and its application in ovarian cancer.

Wang J, Dean DC, Hornicek FJ, Shi H, Duan Z.

Gynecol Oncol. 2019 Jan;152(1):194-201. doi: 10.1016/j.ygyno.2018.10.002. Epub 2018 Oct 5. Review.

PMID:
30297273
20.

Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.

Li X, Seebacher NA, Hornicek FJ, Xiao T, Duan Z.

Cancer Lett. 2018 Dec 28;439:66-77. doi: 10.1016/j.canlet.2018.09.012. Epub 2018 Sep 14. Review.

PMID:
30223067
21.

High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.

Groot OQ, Ogink PT, Janssen SJ, Paulino Pereira NR, Lozano-Calderon S, Raskin K, Hornicek F, Schwab JH.

Clin Orthop Relat Res. 2018 Oct;476(10):2052-2061. doi: 10.1097/CORR.0000000000000463.

22.

From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.

Dean DC, Shen S, Hornicek FJ, Duan Z.

Cancer Metastasis Rev. 2018 Dec;37(4):719-731. doi: 10.1007/s10555-018-9763-8. Review.

PMID:
30167827
23.

Characteristics and Predictors for Secondary Leukemia and Myelodysplastic Syndrome in Ewing and Osteosarcoma Survivors.

Sanford NN, Miao R, Wang H, Goldberg S, Jacobson A, Brunner AM, Cote GM, Yock TI, Ebb DH, Chen YB, Jee KW, Hornicek F, DeLaney TF, Choy E, Chen YL.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):52-61. doi: 10.1016/j.ijrobp.2018.08.037. Epub 2018 Aug 28.

PMID:
30165126
24.

Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Liao Y, Sassi S, Halvorsen S, Feng Y, Shen J, Gao Y, Cote G, Choy E, Harmon D, Mankin H, Hornicek F, Duan Z.

Sci Rep. 2018 Aug 9;8(1):12107. doi: 10.1038/s41598-018-30644-x.

25.

A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma.

Cote GM, Barysauskas CM, DeLaney TF, Schwab J, Raskin K, Lozano-Calderon S, Bernstein K, Mullen JT, Haynes AB, Hornicek F, Chen YE, Choy E.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1496-1504. doi: 10.1016/j.ijrobp.2018.07.2013. Epub 2018 Aug 3.

PMID:
30077789
26.

Henry J. Mankin: A Trailblazer in Skeletal Pathology Research.

Sun CM, Schwab JH, Hornicek FJ.

Spine (Phila Pa 1976). 2018 Jun 8. doi: 10.1097/BRS.0000000000002730. [Epub ahead of print]

PMID:
29889796
27.

Complications and reoperations after surgery for 647 patients with spine metastatic disease.

Paulino Pereira NR, Ogink PT, Groot OQ, Ferrone ML, Hornicek FJ, van Dijk CN, Bramer JAM, Schwab JH.

Spine J. 2019 Jan;19(1):144-156. doi: 10.1016/j.spinee.2018.05.037. Epub 2018 Jun 1.

PMID:
29864546
28.

Lower Extremity Megaprostheses in Orthopaedic Oncology.

Lozano Calderón SA, Kuechle J, Raskin KA, Hornicek FJ.

J Am Acad Orthop Surg. 2018 Jun 15;26(12):e249-e257. doi: 10.5435/JAAOS-D-16-00218.

PMID:
29781818
29.

Functional Outcomes and Complications After Oncologic Reconstruction of the Proximal Humerus.

Nota S, Teunis T, Kortlever J, Ferrone M, Ready J, Gebhardt M, Raskin K, Hornicek F, Schwab J, Lozano Calderon S.

J Am Acad Orthop Surg. 2018 Jun 1;26(11):403-409. doi: 10.5435/JAAOS-D-16-00551.

PMID:
29762195
30.

Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.

Wang J, Garbutt C, Ma H, Gao P, Hornicek FJ, Kan Q, Shi H, Duan Z.

Gynecol Oncol. 2018 Jul;150(1):143-150. doi: 10.1016/j.ygyno.2018.04.557. Epub 2018 Apr 24.

PMID:
29699801
31.

CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.

Liu T, Yan Z, Liu Y, Choy E, Hornicek FJ, Mankin H, Duan Z.

Cell Physiol Biochem. 2018;46(3):1218-1230. doi: 10.1159/000489072. Epub 2018 Apr 16.

32.

Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.

Li X, Seebacher NA, Garbutt C, Ma H, Gao P, Xiao T, Hornicek FJ, Duan Z.

Cell Death Dis. 2018 May 1;9(5):446. doi: 10.1038/s41419-018-0474-4.

33.

Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma.

Ma H, Li X, Wang J, Hornicek FJ, Garbutt CC, Chang X, Duan Z.

Oncology. 2018;95(1):52-60. doi: 10.1159/000487437. Epub 2018 Apr 4.

34.

Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.

Chen H, Shen J, Choy E, Hornicek FJ, Shan A, Duan Z.

Oncotarget. 2017 Nov 28;9(17):13154-13166. doi: 10.18632/oncotarget.22743. eCollection 2018 Mar 2.

35.

What Is the Effect of High-dose Radiation on Bone in Patients With Sacral Chordoma? A CT Study.

van Wulfften Palthe O, Jee KW, Bramer JAM, Hornicek FJ, Chen YE, Schwab JH.

Clin Orthop Relat Res. 2018 Mar;476(3):520-528. doi: 10.1007/s11999.0000000000000063.

36.

HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.

Wang H, Sun W, Sun M, Fu Z, Zhou C, Wang C, Zuo D, Zhou Z, Wang G, Zhang T, Xu J, Chen J, Wang Z, Yin F, Duan Z, Hornicek FJ, Cai Z, Hua Y.

Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1839-1849. doi: 10.1016/j.bbadis.2018.03.008. Epub 2018 Mar 8.

37.

Clinicopathologic characteristics of poorly differentiated chordoma.

Shih AR, Cote GM, Chebib I, Choy E, DeLaney T, Deshpande V, Hornicek FJ, Miao R, Schwab JH, Nielsen GP, Chen YL.

Mod Pathol. 2018 Aug;31(8):1237-1245. doi: 10.1038/s41379-018-0002-1. Epub 2018 Feb 26.

38.

Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma.

Zhou Y, Shen JK, Yu Z, Hornicek FJ, Kan Q, Duan Z.

Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1573-1582. doi: 10.1016/j.bbadis.2018.02.004. Epub 2018 Feb 13.

39.

Extraskeletal osteosarcoma: A large series treated at a single institution.

Wang H, Miao R, Jacobson A, Harmon D, Choy E, Hornicek F, Raskin K, Chebib I, DeLaney TF, Chen YE.

Rare Tumors. 2018 Jan 31;10:2036361317749651. doi: 10.1177/2036361317749651. eCollection 2018.

40.

Management of metastatic humeral fractures: Variations according to orthopedic subspecialty, tumor characteristics.

Janssen SJ, Bramer JAM, Guitton TG, Hornicek FJ, Schwab JH.

Orthop Traumatol Surg Res. 2018 Feb;104(1):59-65. doi: 10.1016/j.otsr.2017.11.008. Epub 2017 Dec 14.

41.

Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications.

Xiao X, Garbutt CC, Hornicek F, Guo Z, Duan Z.

Cancer Treat Rev. 2018 Feb;63:61-70. doi: 10.1016/j.ctrv.2017.12.001. Epub 2017 Dec 6. Review.

PMID:
29247978
42.

CDK4 expression in chordoma: A potential therapeutic target.

Liu T, Shen JK, Choy E, Zhang Y, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2018 Jun;36(6):1581-1589. doi: 10.1002/jor.23819. Epub 2017 Dec 22.

43.

Advances in sarcoma gene mutations and therapeutic targets.

Gao P, Seebacher NA, Hornicek F, Guo Z, Duan Z.

Cancer Treat Rev. 2018 Jan;62:98-109. doi: 10.1016/j.ctrv.2017.11.001. Epub 2017 Nov 11. Review.

PMID:
29190505
44.

Synovial sarcoma of the shoulder: A series of 14 cases.

Verbeek BM, Kaiser CL, Larque AB, Hornicek FJ, Raskin KA, Schwab JH, Chen YL, Lozano Calderón SA.

J Surg Oncol. 2018 Mar;117(4):788-796. doi: 10.1002/jso.24889. Epub 2017 Nov 22.

PMID:
29165811
45.

Primary arthroplasty in healed osteoarticular allograft in patients with history of primary femoral bone tumors.

Verbeek BM, Kaiser CL, Paulino Pereira NR, Hornicek FJ, Raskin KA, Schwab JH, LozanoCalderón SA.

Surg Oncol. 2017 Dec;26(4):498-505. doi: 10.1016/j.suronc.2017.10.003. Epub 2017 Oct 5.

PMID:
29113670
46.

Noncoding RNA in drug resistant sarcoma.

Li X, Shen JK, Hornicek FJ, Xiao T, Duan Z.

Oncotarget. 2017 Jul 6;8(40):69086-69104. doi: 10.18632/oncotarget.19029. eCollection 2017 Sep 15. Review.

47.

Regulation of microRNAs function by circular RNAs in human cancer.

Han C, Seebacher NA, Hornicek FJ, Kan Q, Duan Z.

Oncotarget. 2017 Aug 4;8(38):64622-64637. doi: 10.18632/oncotarget.19930. eCollection 2017 Sep 8. Review.

48.

Modified En Bloc Spondylectomy for Tumors of the Thoracic and Lumbar Spine: Surgical Technique and Outcomes.

Shah AA, Paulino Pereira NR, Pedlow FX, Wain JC, Yoon SS, Hornicek FJ, Schwab JH.

J Bone Joint Surg Am. 2017 Sep 6;99(17):1476-1484. doi: 10.2106/JBJS.17.00141.

PMID:
28872530
49.

Chordoma arising from benign multifocal notochordal tumors.

Arain A, Hornicek FJ, Schwab JH, Chebib I, Damron TA.

Skeletal Radiol. 2017 Dec;46(12):1745-1752. doi: 10.1007/s00256-017-2727-1. Epub 2017 Aug 3.

PMID:
28776089
50.

Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Tang F, Choy E, Tu C, Hornicek F, Duan Z.

Cancer Treat Rev. 2017 Sep;59:33-45. doi: 10.1016/j.ctrv.2017.06.006. Epub 2017 Jul 6. Review.

Supplemental Content

Loading ...
Support Center